Medworxx Unveils the Next Generation Patient Flow Solution

TORONTO--(BUSINESS WIRE)--Medworxx Inc. (“Medworxx”) (TSXV: MWX), a leader in patient flow solutions, announced today the launch of Medworxx 5.0. This new web-based, integrated Patient Flow solution, comprised of Medworxx Utilization Management, Medworxx Bed Board, Medworxx Assessments, and Medworxx Dashboard & Analytics, is available as a software-as-a-service (SaaS) single solution.

“While the individual modules within the Medworxx 5.0 can be licensed separately, the functionality and data are fully integrated. Medworxx clients will truly have the ability to optimize appropriate care transitions and reduce readmissions across the continuum of care.”

Medworxx 5.0 is built on a platform that provides sharing of data and functionality across all modules. Medworxx clients will benefit from a reporting & analysis dashboard with pre-built reports, charts and indicators needed to make proactive decisions about improvement opportunities in care transitions and readmissions.

Offered as a SaaS solution, Medworxx 5.0 clients will be able to quickly and cost-effectively maximize the value of their investment. Medworxx 5.0 will allow clients to rapidly gain the benefit of their Patient Flow software without significant start-up costs. Clients can focus on their critical business initiatives and change process, while Medworxx enables the software.

“We are excited to introduce this unique offering into the healthcare marketplace,” said Dan Matlow, President and CEO at Medworxx. “While the individual modules within the Medworxx 5.0 can be licensed separately, the functionality and data are fully integrated. Medworxx clients will truly have the ability to optimize appropriate care transitions and reduce readmissions across the continuum of care.”

With 33% of the Canadian acute care beds and approximately 1,000 beds in the UK, Medworxx bridges clinical and operational patient flow perspectives with an increased focus on the “appropriateness” of care. Medworxx 5.0 provides insight into a large number of potential patient flow barriers in an easy-to-share and easy-to-read format for actionable and measurable improvement opportunities.

Mr. Matlow said, “The availability of this new offering will greatly assist us in our international distribution strategy. We strongly believe this new solution provides a compelling business case for our existing clients as well as new prospective clients to license the full patient flow solution.”

About Medworxx

Medworxx delivers health information technology solutions to over 350 hospitals internationally; including Canada, United States and United Kingdom. Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education. Medworxx Utilization Management system—flagship of Medworxx Patient Flow that includes electronic bed board and independent assessment components—currently serves over 33% of the acute care beds in Canada. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and publicly traded on the TSX Venture Exchange: MWX

Visit www.medworxx.com

The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.

Disclaimer

The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.